IOVA — Iovance Biotherapeutics, Inc. stock price, charts and financials

QT67Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.36
+0.04+0.93%
OverviewShort InterestFilings
IOVAQT67Iovance Biotherapeutics, Inc.·NASDAQ
4.36+0.93%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 02, 20268-KCurrent report
Jun 18, 2026S-8Registration of employee benefit securities
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 2026S-8Registration of employee benefit securities
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 2026S-3ASRS-3ASR
Jun 18, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 01, 2026ARSAnnual report to shareholders
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 357
Page
▼
/ 15